Selwyn Yorke is a biotech consultant, a Director who holds two Chair and three Board positions on deep tech start-up organisations. He has several Advisory roles and enjoys being a business mentor (BMNZ). To support environmental recovery, Selwyn Chairs a community-based native tree planting and environmental management group. He is an Impact Advisor to groups at two Research Institutions.
Selwyn is an Investment Committee member of the Manawatu Investment Group Fund 3 in which he assesses many types of start-up companies, including foodtech, biotech, agritech and SaaS businesses for investment opportunities. Furthermore, he is a member of the Return on Science Manawatu Momentum committee and recently became a Chiasma Manawatu mentor.
Selwyn has a career of project management related activities including drug development, medical devices, natural products and related technology, including early-stage manufacturing.
Selwyn was Business Development Manager at New Zealand Pharmaceuticals Ltd (NZP), a GMP certified manufacturer of drug substances, pharmaceutical intermediates and natural products. He contributed to global sales of a range of NZP products and retired from NZP in June, 2016.
Selwyn is a graduate of the University of Canterbury (PhD chemistry) and in the post-grad period, he worked in academia for several years, in a tech start-up and at the Chemistry Division, DSIR.
